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intervention (PCI).
Methods: Fifty-three patients who were done PCI recently were randomized to full
medical treatments or additional 3 months regular exercise program. FMD and carotid
IMT was measured and circulating CD34+/KDR+, CD34+/CD117+ and
CD34+/CD133+ EPCs were quantified by flow cytometry at baselines and after 3
months exercise.
Results: Finally 17 patients joined exercise program, and 28 patients were control
group. After 3 months, FMD improved significantly in exercise group (5.39% to
11.6%) compared with control group (8.62% to 9.2%). After adjusting baseline FMD,
age and sex using univariate analysis of covariance, P value was 0.016.(figure) Carotid
IMT reduced significantly in exercise group (0.82mm to 0.746mm) compared with
control group (0.754mm to 0.746mm) (P=0.008). Numbers of CD34+/CD117+ and
CD34+/CD133+ EPCs increased significantly after exercise compared with control
group (P=0.022, 0.017) (figure).
Conclusion: Three months regular aerobic exercise training improved FMD and
carotid IMT in PCI patients. and it augmented numbers of circulating EPCs.
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Background: Mean platelet volume (MPV) is one of the platelet function indices
which reflects the platelet production rate and stimulation. The aim of this study is to
evaluate the impact of MPV on one year clinical outcomes in patients underwent
percutaneous coronary intervention (PCI).
Methods: A total 1215 patients (Age; 63.43 ± 11.55, Men; 66.3 %) underwent PCI
were enrolled. We examined the MPV before coronary angiogram. We evaluated the
relation between MPV and major adverse cardiac events (MACEs)
Results: One year after PCI, 138 MACEs were developed. MPV was higher in MACEs
group compared with that in Non-MACEs group (respectively, 8.66± 1.41 fl vs. 8.38±
1.26 fl, p = 0.031) In multivariate analysis, MPV was a independent predictor for one
year MACEs (OR; 1.183, p=0.027).
Odds ratios of risk factors for 12 Month MACEs.
Conclusion: This study identified that high MPV as an independent risk factor for one
year MACEs in patients who underwent PCI.
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Background: Limited randomized data is available regarding treatment strategies in
elderly patients. We performed a patient-pooled analysis of a routine invasive (RI)
versus selective invasive (SI) strategy in elderly patients.
Methods: In the FRISC II–ICTUS–RITA-3 (FIR) patient-pooled database, we
compared outcomes after a RI versus SI strategy according to age categories. The main
outcome was 5-year cardiovascular death or myocardial infarction (MI). (Un)adjusted
hazard ratios (HR) were calculated with Cox regression, with adjustments for variables
associated with age and outcomes.
Results: Regarding 5-year cardiovascular death or MI, the RI strategy was associated
with a lower hazard in the 65-74 years (HR 0.72, 95%CI:0.58-0.90) and the ≥75 years
(HR 0.71, 95%CI:0.55-0.91), but not in the <65 years category (HR 1.11, 95%CI:0.90-
1.38), p=0.001 for interaction between treatment strategy and age (figure). The
interaction was driven by an excess of early MIs in patients <65 years of age while
there was no heterogeneity between age groups concerning cardiovascular death. The
benefits were smaller for women then men (p for interaction 0.009). After adjustment
for other clinical risk factors the HRs remained similar.
Conclusion: The current analysis of the FIR dataset shows that the long-term benefit
of a RI over a SI strategy is attenuated in younger patients <65 years of age and in
females by the raised risk of early events which seem to have no consequences for
long-term cardiovascular mortality. No other clinical risk factors were able to identify
patients with differential responses to a RI strategy.
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